X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (112) 112
life sciences & biomedicine (109) 109
anti-pd-l1 (93) 93
immunotherapy (87) 87
humans (66) 66
oncology (65) 65
anti-pd-1 (50) 50
cancer (32) 32
animals (30) 30
antibodies, monoclonal - therapeutic use (28) 28
b7-h1 antigen - antagonists & inhibitors (28) 28
immunology (27) 27
tumors (27) 27
immune checkpoint (24) 24
antibodies (23) 23
pd-l1 protein (22) 22
apoptosis (21) 21
female (21) 21
immunotherapy - methods (21) 21
chemotherapy (20) 20
anti-ctla-4 (19) 19
b7-h1 antigen - immunology (18) 18
cancer therapies (18) 18
lung cancer (18) 18
anti-pd-l1 antibody (17) 17
lymphocytes (17) 17
metastasis (17) 17
mice (17) 17
patients (17) 17
antibodies, monoclonal - pharmacology (16) 16
cell death (16) 16
pembrolizumab (16) 16
programmed cell death 1 receptor - antagonists & inhibitors (16) 16
antineoplastic agents - therapeutic use (15) 15
melanoma (15) 15
care and treatment (14) 14
immune checkpoint inhibitors (14) 14
ligands (14) 14
nivolumab (14) 14
clinical trials (13) 13
lymphocytes t (13) 13
neoplasms - immunology (13) 13
checkpoint inhibitor (12) 12
male (12) 12
neoplasms. tumors. oncology. including cancer and carcinogens (12) 12
pd-1 protein (12) 12
t cells (12) 12
analysis (11) 11
avelumab (11) 11
cytotoxicity (11) 11
middle aged (11) 11
toxicity (11) 11
aged (10) 10
b7-h1 antigen - metabolism (10) 10
cell line, tumor (10) 10
checkpoint inhibitors (10) 10
ctla-4 antigen - antagonists & inhibitors (10) 10
respiratory system (10) 10
antigens (9) 9
anti‐pd‐l1 (9) 9
cd8 antigen (9) 9
health aspects (9) 9
lung cancer, non-small cell (9) 9
lung neoplasms - drug therapy (9) 9
medicine & public health (9) 9
medicine, research & experimental (9) 9
neoplasms - drug therapy (9) 9
research & experimental medicine (9) 9
review (9) 9
adult (8) 8
antibodies, monoclonal - adverse effects (8) 8
antineoplastic agents - pharmacology (8) 8
cell biology (8) 8
immune checkpoint blockade (8) 8
immune system (8) 8
ipilimumab (8) 8
lung neoplasms - therapy (8) 8
metastases (8) 8
non-small cell lung cancer (8) 8
nsclc (8) 8
programmed cell death 1 receptor - immunology (8) 8
viral antibodies (8) 8
antibodies, monoclonal - immunology (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
biomarkers (7) 7
biotechnology & applied microbiology (7) 7
ctla-4 protein (7) 7
disease models, animal (7) 7
drug therapy (7) 7
immune checkpoint inhibitor (7) 7
immunoglobulins (7) 7
mice, inbred c57bl (7) 7
monoclonal antibodies (7) 7
neoplasms - therapy (7) 7
non-small cell lung carcinoma (7) 7
pd-l1 (7) 7
programmed cell death 1 receptor - metabolism (7) 7
animal models (6) 6
antibodies, monoclonal - administration & dosage (6) 6
antibodies, monoclonal, humanized - adverse effects (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of cancer, ISSN 0020-7136, 08/2017, Volume 141, Issue 3, pp. 583 - 593
Journal Article
Journal Article
Journal Article
Case Reports in Ophthalmology, ISSN 1663-2699, 07/2018, Volume 9, Issue 2, pp. 348 - 356
...). Here, we report a rare case of optic neuritis and hypopituitarism during anti-programmed death-ligand 1 (PD-L1) antibody treatment. Case Presentation... 
Case Report | Anti-PD-L1 antibody | Immune-related adverse effects | Hypopituitarism | Optic neuritis | Immunoglobulins | Medical imaging | Nuclear magnetic resonance--NMR | Cytokines | Melanoma | Systematic review | Metastasis | Patients | Cancer therapies | Defects | Pain | Lymphocytes | Growth hormones | Ophthalmology
Journal Article